The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37

Current Opinion in Virology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles